Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
What Analysts Are Saying About DexCom Stock
Via Benzinga
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand. 
Via MarketBeat
3 Breakthrough Medical Device Stocks to Invest In Now
Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead. 
Via InvestorPlace
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
2 Top Growth Stocks to Buy With $1,000
These stocks have excellent track records of beating the market. 
Via The Motley Fool
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase.
Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact. 
Via InvestorPlace
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio. 
Via InvestorPlace
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
From DexCom, Inc.
Via Business Wire
The 3 Best Diabetes Stocks to Buy in June 2024
There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy. 
Via InvestorPlace
Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today
Via Benzinga
Peering Into DexCom's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today
Via Benzinga
What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024)
Via Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device. 
Via Investor's Business Daily
Exposures Product Safety
Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor
Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone. 
Via Benzinga
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
From DexCom, Inc.
Via Business Wire
In-Depth Examination Of 6 Analyst Recommendations For DexCom
Via Benzinga
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
From Dexcom, Inc.
Via Business Wire
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
Innovation is paying off for both of these medical device specialists. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat. 
Via The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
From Tandem Diabetes Care, Inc.
Via Business Wire
3 Growth Stocks the New ‘GPT-4o’ AI Bot Says Will Make You Rich
These three under-the-radar growth stocks picked by the new GPT-4o AI bot could deliver massive gains if the AI model is right. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Google Parent Alphabet Is Selling Shares of 2 Hypergrowth Stocks and Piling Into a Promising Artificial Intelligence (AI) Company
Alphabet oversees more than $2.5 billion of invested assets. In the March quarter, it dumped shares of two of its largest holdings and nearly quadrupled its stake in a fast-growing artificial... 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.